BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24953023)

  • 1. The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells.
    Riccio M; Carnevale G; Cardinale V; Gibellini L; De Biasi S; Pisciotta A; Carpino G; Gentile R; Berloco PB; Brunelli R; Bastianelli C; Napoletano C; Cantafora A; Cossarizza A; Gaudio E; Alvaro D; De Pol A
    J Hepatol; 2014 Nov; 61(5):1097-105. PubMed ID: 24953023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
    Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
    Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection.
    Guillermo LV; Silva EM; Ribeiro-Gomes FL; De Meis J; Pereira WF; Yagita H; DosReis GA; Lopes MF
    J Leukoc Biol; 2007 Apr; 81(4):942-51. PubMed ID: 17261545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD95 (FAS) and CD178 (FASL) induce the apoptosis of CD4+ and CD8+ cells isolated from the peripheral blood and spleen of dogs naturally infected with Leishmania spp.
    Silva KL; Melo LM; Perosso J; Oliveira BB; Santos PS; Eugênio Fde R; Lima VM
    Vet Parasitol; 2013 Nov; 197(3-4):470-6. PubMed ID: 23920055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation.
    Singh RK; Varney ML; Buyukberber S; Ino K; Ageitos AG; Reed E; Tarantolo S; Talmadge JE
    Cancer Res; 1999 Jul; 59(13):3107-11. PubMed ID: 10397252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells.
    Urayama S; Kawakami A; Matsuoka N; Tsuboi M; Nakashima T; Kawabe Y; Koji T; Eguchi K
    Biochem Biophys Res Commun; 1997 Oct; 239(3):782-8. PubMed ID: 9367846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human retinal pigment epithelial cell-induced apoptosis in activated T cells.
    Jørgensen A; Wiencke AK; la Cour M; Kaestel CG; Madsen HO; Hamann S; Lui GM; Scherfig E; Prause JU; Svejgaard A; Odum N; Nissen MH; Röpke C
    Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1590-9. PubMed ID: 9699548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased lymphocyte apoptosis in Fas ligand transgenic mice.
    Cheng J; Liu C; Yang P; Zhou T; Mountz JD
    J Immunol; 1997 Jul; 159(2):674-84. PubMed ID: 9218582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: CD4+ T cells kill CD8+ T cells via Fas/Fas ligand-mediated apoptosis.
    Piazza C; Gilardini Montani MS; Moretti S; Cundari E; Piccolella E
    J Immunol; 1997 Feb; 158(4):1503-6. PubMed ID: 9029083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients.
    Körner C; Tolksdorf F; Riesner K; Krämer B; Schulte D; Nattermann J; Rockstroh JK; Spengler U
    Antivir Ther; 2011; 16(7):1047-55. PubMed ID: 22024520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age related changes in Fas (CD95) and Fas ligand gene expression and cytokine profiles in healthy Indians.
    Sawhney M; Mathew M; Valarmathi MT; Das SN
    Asian Pac J Allergy Immunol; 2006 Mar; 24(1):47-56. PubMed ID: 16913188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen immunotherapy decreases specific allergen-induced expression of Fas and FasL on CD4+ and CD8+ cells.
    Zak-Nejmark T; Nowak IA; Malolepszy J
    J Investig Allergol Clin Immunol; 2005; 15(1):63-8. PubMed ID: 15864885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of activated but not resting primary human CD4+ and CD8+ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells.
    Hoves S; Krause SW; Herfarth H; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    Immunobiology; 2004; 208(5):463-75. PubMed ID: 15124861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lack of Fas/FasL signalling leads to disturbances in the antiviral response during ectromelia virus infection.
    Bień K; Sobańska Z; Sokołowska J; Bąska P; Nowak Z; Winnicka A; Krzyzowska M
    Arch Virol; 2016 Apr; 161(4):913-28. PubMed ID: 26780774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway.
    Furukawa H; Oshima K; Tung T; Cui G; Laks H; Sen L
    Transplantation; 2008 Feb; 85(3):437-46. PubMed ID: 18301335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
    Arnold R; Seifert M; Asadullah K; Volk HD
    J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro.
    Gupta M; Spiropoulou C; Rollin PE
    Virology; 2007 Jul; 364(1):45-54. PubMed ID: 17391724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.
    Muppidi JR; Siegel RM
    Nat Immunol; 2004 Feb; 5(2):182-9. PubMed ID: 14745445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
    Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
    J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells.
    Carnevale G; Carpino G; Cardinale V; Pisciotta A; Riccio M; Bertoni L; Gibellini L; De Biasi S; Nevi L; Costantini D; Overi D; Cossarizza A; de Pol A; Gaudio E; Alvaro D
    Sci Rep; 2017 Oct; 7(1):14419. PubMed ID: 29089545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.